ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Indonesia's first biomedicine factory opens

Kalbe Farma aims for higher margins with biological products

Kalbe Farma President Vidjongtius, right, gives Indonesian President Joko Widodo a tour of the company's new biomedicine factory outside Jakarta on Feb. 27 (Photo from Indonesia's Ministry of Industry)

JAKARTA -- Indonesia's largest pharmaceutical company, Kalbe Farma, inaugurated its first biological drug factory on Tuesday, as it aims to produce higher-margin prescription drugs amid heated competition in the country's pharmaceutical industry.

The factory, run by subsidiary Kalbio Global Medika, sits across an 11,000-square-meter site in an industrial zone in Cikarang, east of Jakarta. Kalbe invested 500 billion rupiah ($35 million) to construct the factory. Another 200 billion rupiah has been set aside to support research and development, and to transfer technology from Chinese and South Korean partners to support the operation, Kalbe said in a press statement.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more